G. Marcias

Unexpected paracrine action of prostate cancer cells harboring a new class of androgen receptor mutation—A new paradigm for cooperation among prostate tumor cells

D. Jacqmin, H. Lang, J. Céraline, 2007, International journal of cancer.

Suppressor of cytokine signaling (SOCS)-1 is expressed in human prostate cancer and exerts growth-inhibitory function through down-regulation of cyclins and cyclin-dependent kinases.

L. Kenner, M. Susani, A. Hobisch, 2009, The American journal of pathology.

Tumorigenesis and Neoplastic Progression Suppressor of Cytokine Signaling ( SOCS )-1 Is Expressed in Human Prostate Cancer and Exerts Growth-Inhibitory Function through Down-Regulation of Cyclins and Cyclin-Dependent Kinases

L. Kenner, M. Susani, A. Hobisch, 2010 .

Identification of novel truncated androgen receptor (AR) mutants including unreported pre‐mRNA splicing variants in the 22Rv1 hormone‐refractory prostate cancer (PCa) cell line

J. Céraline, B. Duclos, J. Bergerat, 2010, Human mutation.

SOCS-3 antagonises the proliferative and migratory effects of fibroblast growth factor-2 in prostate cancer by inhibition of p44/p42 MAPK signalling.

A. Hobisch, Z. Culig, M. Puhr, 2010, Endocrine-related cancer.

CITED4 gene silencing in colorectal cancer cells modulates adherens/tight junction gene expression and reduces cell proliferation

P. Lichter, M. Zapatka, V. Kalter, 2015, Journal of Cancer Research and Clinical Oncology.

Specific properties of a C-terminal truncated androgen receptor detected in hormone refractory prostate cancer.

J. Céraline, J. Bergerat, P. Kessler, 2008, Advances in experimental medicine and biology.

Specific properties of a C-terminal truncated androgen receptor detected in hormone refractory prostate cancer.

J. Céraline, J. Bergerat, P. Kessler, 2008, Advances in experimental medicine and biology.